As of 2024-12-14, the Intrinsic Value of Aptose Biosciences Inc (APS.TO) is
-20.48 CAD. This APS.TO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.28 CAD, the upside of Aptose Biosciences Inc is
-7,545.82%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-20.48 CAD
Intrinsic Value
APS.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
Fair Value |
-20.48 - -20.48 |
-20.48 |
-7,545.82% |
P/E |
(16.20) - (4.24) |
(11.89) |
-4423.8% |
DDM - Stable |
(11.52) - (40.68) |
(26.10) |
-9591.2% |
DDM - Multi |
(9.91) - (29.98) |
(15.22) |
-5633.7% |
APS.TO Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
7.53 |
Beta |
-0.49 |
Outstanding shares (mil) |
27.38 |
Enterprise Value (mil) |
-2.87 |
Market risk premium |
5.10% |
Cost of Equity |
13.73% |
Cost of Debt |
5.00% |
WACC |
8.71% |